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Abstract 
Introduction  
Type 2 diabetes is the most common form of diabetes affecting a large population worldwide. Vitamin D receptor (VDR) is a 
main transcription factor that has been linked to type 2 diabetes.  
Objective 
The aim of this study is to assess the Genetic Association Studies (GAS) referred to the Vitamin D Receptor (VDR) polymorphisms 
TaqI, BsmI, FokI and ApaI and type 2 diabetes mellitus (T2DM). 
Methods 
After an extended search of genetic association studies, each study was assessed – according to the standards set by literature, 
described in detail – and then a meta-analysis was performed for each polymorphism.  
Results 
The meta-analysis involved 13 studies, for TaqI polymorphism 8 studies were included (1134 cases + 978 controls). Overall, the 
results indicate that heterozygotes (TC) are protected of type 2 diabetes – there is a smaller chance for the heterozygotes to be 
affected by the disease than for the homozygotes (TT+CC) – as indicated by the OR that was significant [FE OR=0.776/ 95% CI = 
(0.625, 0.964) / RE OR=0.771 / 95% CI = (0.600, 0.991)]. There was no heterogeneity (I2 =22.55 %), meaning variations are due to 
chance.   
For BsmI polymorphism, 7 studies were included in the meta-analysis (1067 cases + 1466 controls). In subgroup analysis (4 case-
control studies/315 cases & 356 controls) for Caucasians – with dark skin [including Indians and Moroccans but not Hui Chinese 
(descendants of Arabic & Persian merchants)] the results indicate that carriers of the A allele (AA+AG) have a higher risk of 
acquiring type 2 diabetes – as indicated by the OR that was significant [FE OR=1.4824 / 95% CI = (1.0309, 2.1317) /RE OR=1.494 / 
95% CI = (1.017, 2.196)]. There was no heterogeneity (I2 = 8.07 %). When Hui Chinese were included in the subgroup of 
Caucasians – with dark skin, the results were not significant and there was medium heterogeneity (I2 = 35.7 %). But, after 
repeating the analysis – without the study that included 30 (out of 40) related patients – no significant associations were 
found and there was no heterogeneity since I2<25%. 
For FokI polymorphism, 7 studies were included in the meta-analysis (1960 cases + 1965 controls). In subgroup analysis (2 case-
control studies/ 298 cases & 332 controls) for the mixed population of Chile [35% Caucasians, 60% Castizos/ Mestizos = 60% 
Caucasians and 40% native Americans, 5% native Americans] the results indicate that: a) heterozygotes CT have a higher risk of 
acquiring type 2 diabetes compared to the homozygotes (CC+TT) – as indicated by the OR that was significant [FE OR=1.775, 
95% CI = (1.2916, 2.4393) /RE OR=1.747, 95% CI = (1.612, 1.893)]. There was no heterogeneity (I2 = 0%), b) heterozygotes CT 
have a higher risk of acquiring type 2 diabetes compared to the homozygotes CC – as indicated by the OR (CC vs CT) that was 
significant [FE OR=0.4563, 95% CI = (0.3007, 0.6842)]. There was medium heterogeneity (I2 = 34.74%).   
For ApaI 3 studies were included in the meta-analysis (473 cases + 429 controls) but no statistically significant association was 
detected. 
Conclusion 
It would be useful to further investigate the possible associations of the 4 VDR polymorphisms with type 2 diabetes, especially 
TaqI polymorphism and FokI in mixed populations like the one in Chile (possibly native American ancestry may explain the 
differences), that showed a significant association. 
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Περίληψη 
Εισαγωγή 
Ο διαβήτης τύπου 2 είναι η πιο συχνή μορφή διαβήτη που επηρεάζει μεγάλο μέρος του πληθυσμού παγκοσμίως. Ο υποδοχέας 
της βιταμίνης D (VDR) είναι ένας κύριος μεταγραφικός παράγοντας που έχει συνδεθεί με τον διαβήτη τύπου 2. 
Στόχοι 
Στόχος της μελέτης είναι η αξιολόγηση των Μελετών Γενετικής Συσχέτισης που αναφέρεται στους πολυμορφισμούς της VDR 
TaqI, BsmI, FokI και ApaI και τον διαβήτη τύπου 2. 
Μέθοδοι 
Μετά από εκτεταμένη αναζήτηση μελετών γενετικής συσχέτισης, κάθε μελέτη αξιολογήθηκε – σύμφωνα με τις προδιαγραφές 
που ορίζονται από τη βιβλιογραφία και αναλύονται λεπτομερώς – και κατόπιν πραγματοποιήθηκε μετα-ανάλυση για κάθε 
πολυμορφισμό. 
Αποτελέσματα 
Για τον πολυμορφισμό TaqI, 8 μελέτες περιλήφθηκαν στην μετα-ανάλυση (1134 ασθενείς+978 υγιείς). Συνολικά, τα 
αποτελέσματα υποδεικνύουν ότι οι ετερόζυγοι (TC) είναι προστατευμένοι από τον διαβήτη τύπου 2, καθώς υπάρχει μικρότερη 
πιθανότητα οι ετερόζυγοι να εμφανίσουν την ασθένεια συγκριτικά με τους ομόζυγους (TT+CC) σύμφωνα με το OR που ήταν 
στατιστικά σημαντικό [FE OR=0.776/ 95% CI = (0.625, 0.964) / RE OR=0.771 / 95% CI = (0.600, 0.991)]. Δεν παρατηρείται 
ετερογένεια, δηλαδή οι διακυμάνσεις οφείλονται στην τύχη (I=22.5%).  
Για τον πολυμορφισμό BsmI, 7 μελέτες περιλήφθηκαν στην μετα-ανάλυση (1067 ασθενείς + 1466 υγιείς). Στην ανάλυση 
υποομάδων (4 μελέτες/315 ασθενείς & 356 υγιείς) σε Καυκάσιους – με σκούρο δέρμα [Ινδοί και Μαροκινοί αλλά όχι οι Κινέζοι 
Hui (που είναι απόγονοι Αράβων & Περσών εμπόρων)] τα αποτελέσματα υποδεικνύουν ότι οι φορείς του αλληλομόρφου A 
(AA+AG) έχουν μεγαλύτερο κίνδυνο να εμφανίσουν διαβήτη τύπου 2 σύμφωνα με το OR που ήταν στατιστικά σημαντικό [FE 
OR=1.4824 / 95% CI = (1.0309, 2.1317) /RE OR=1.494 / 95% CI = (1.017, 2.196)]. Δεν παρατηρείται ετερογένεια (I2 = 8.07 %). 
Όταν περιλήφθηκαν οι Hui στους Καυκάσιους τα αποτελέσματα δεν ήταν στατιστικά σημαντικά. Όμως, αν αφαιρέσουμε τη 
μελέτη – όπου συμπεριελήφθησαν 30 (από τους 40) ασθενείς με συγγενικές σχέσεις – δεν βρίσκουμε στατιστικά σημαντικά 
αποτελέσματα ενώ δεν παρατηρείται ετερογένεια (I2 <25%). 
Για τον πολυμορφισμό FokI, 7 μελέτες περιλήφθηκαν στην μετα-ανάλυση (1960 ασθενείς + 1965 υγιείς). Στην ανάλυση 
υποομάδων (2 μελέτες/ 298 ασθενείς & 332 υγιείς) σε μικτό πληθυσμό[35% Καυκάσιοι, 60% Castizos/ Mestizos = 60% 
Καυκάσιοι and 40% γηγενείς Αμερικανοί, 5% γηγενείς Αμερικανοί], τα αποτελέσματα υποδεικνύουν ότι: α) οι ετερόζυγοι CT 
έχουν μεγαλύτερο κίνδυνο να εμφανίσουν διαβήτη τύπου 2 συγκριτικά με τους ομόζυγους (CC+TT) σύμφωνα με το OR που 
ήταν στατιστικά σημαντικό [FE OR=1.775, 95% CI = (1.2916, 2.4393) /RE OR=1.747, 95% CI = (1.612, 1.893)]. Δεν παρατηρείται 
ετερογένεια (I2 = 0%), b) οι ετερόζυγοι CT έχουν μεγαλύτερο κίνδυνο να εμφανίσουν διαβήτη τύπου 2 συγκριτικά με τους 
ομόζυγους CC σύμφωνα με το OR που είναι στατιστικά σημαντικό [FE OR=0.4563, 95% CI = (0.3007, 0.6842)]. Παρατηρείται 
μέτρια ετερογένεια (I2 = 34.74%). 
Για τον πολυμορφισμό ApaI 3 μελέτες περιλήφθηκαν στην μετα-ανάλυση (473 ασθενείς + 429 υγιείς) όμως δεν παρατηρήθηκε 
στατιστικά σημαντική σχέση. 
 
Συμπεράσματα 
Θα ήταν χρήσιμη η περεταίρω έρευνα της πιθανής συσχέτισης των 4 πολυμορφισμών με τον διαβήτη τύπου 2, ειδικά για τον 
πολυμορφισμό TaqI και για τον πολυμορφισμό FokI σε μικτούς πληθυσμούς όπως αυτός της Χιλής (πιθανή εξήγηση για τις 
διαφορές που παρατηρήθηκαν είναι η γηγενής Αμερικανική καταγωγή),  καθώς δείχθηκε στατιστικά σημαντική συσχέτιση. 
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INTRODUCTION 
For complex traits, like diabetes, association studies are more powerful than linkage because the causal risk factor is measured 
[1]. 
Diabetes mellitus is a heterogeneous metabolic disorder characterized by the presence of hyperglycemia due to impairment of 
insulin secretion, defective insulin action or both. The chronic hyperglycemia of diabetes is associated relatively specific long-
term microvascular complications effecting the eyes, kidneys and nerves as well as increased risk of cardiovascular disease. Type 
2 diabetes may range from predominant insulin resistance with relative insulin deficiency to a predominant secretory defect 
with insulin resistance. Ketosis is not as common [2]. 
Type 2 diabetes is associated with serious morbidity and increased mortality. Type 2 diabetes is the most common of diabetes 
accounting for 85-90% of all cases. Worldwide the total number of people with diabetes is expected to rise from 171 million in 
2000 to 366 million by 2030 [3].  
Vitamin D may play a role in modifying risk of diabetes since there has been increasing evidence from animal and human studies 
[4]. Vitamin D binds to the cytosolic/nuclear Vitamin D Receptor – VDR, which is a member of the steroid/thyroid hormone 
receptor family that functions as a transcriptional activator of many genes. VDR is expressed in tissues like muscle and 
pancreatic β cells that are involved in the regulation of glucose metabolism ([5], [6], [7], [8]). Additionally, the existence of a 
putative membrane VDR (mVDR) has been postulated [9] and it has been shown that pancreatic β cells express both specific 
cytosolic/nuclear VDR and the putative membrane VDR (mVDR) [10]. As stated by A.G. Pittas et al. in 2007 ([4]), vitamin D is 
thought to have both direct (by the activation of the vitamin D receptor) and indirect (by the regulation of calcium homeostasis) 
effects on various mechanisms related to the pathophysiology of type 2 diabetes, including impaired pancreatic -b cell function 
and insulin resistance. 
As stated by Palomer X et al. in 2008 ([11]), vitamin D modulates insulin secretion it is feasible that genetic variants of the VDR 
gene may contribute to the development of type 2 diabetes mellitus and since patients with type 2 diabetes exhibit subtle 
alterations in glucose metabolism long before the onset of the disease, genetic factors contributing to its pathogenesis or 
development could be detected early in the disease process.  
Polymorphisms are variations in the genetic code that are present in more than 1% of the population. Four polymorphisms of 
the VDR gene, that are described in detail, are Fok I, Bsm I, Apa I, Taq I: 
   
Image by Uitterlinden et al. in 2004 ([12]) 
Type 2 diabetes is initiated by insulin resistance and β cell dysfunction is characterized by defective insulin secretion, 
endoplasmic reticulum (ER) stress, eventual β cell loss and disease progression ([13], [14], [15], [16]). 
Although the molecular underpinnings of obesity-induced β cell dysfunction is poorly understood, increasing evidence links 
inflammation and specifically the innate immune response of pancreatic islets to metabolic stress, to type 2 diabetes 
progression ([17], [18], [19]). 
  
Z. Wei et al. in 2018 ([20]) identified VDR as a key modulator of inflammation and β-cell survival, so an unusual therapeutic 
strategy was uncovered in which the inflammation could be suppressed via sustained VD receptor activation in β-cells.   
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METHODS  
LITERATURE SEARCH 
The following searched criterion was used: “VDR” or “BsmI” or “TaqI” or “ApaI” or “FokI” or “BsmI” or “Taq1” or “Apa1” or 
“Fok1” and “type 2 diabetes” or “T2D” or “type 2 diabetes mellitus” or “T2DM”. The genetic association studies published from 
2008 to 2018, in English and in full text form, were included.   
QUALITY ASSESSMENT CRITERIA 
To assess a genetic association study, it is important to define the correct steps in designing and conducting such a study ([21]). 
Our goal is to examine the association of VDR polymorphisms and diabetes type 2. We should take under consideration, to 
evaluate each genetic association study ([22]) the following matters: 
1. The gene of interest should be chosen based on a certain biological mechanism.  
2. The sequence of normal variants should be determined as well as the frequency in certain populations of interest. 
3. The effect of the polymorphism (frequency>1%) on the function of the gene should be mentioned and cited. 
4. Haplotype analysis. The genotyping of a specific combination of polymorphisms that represent all common haplotypes 
(frequency>5% in the population under study) helps to ensure that the entire gene is represented in the analysis. 
Polymorphisms found to be associated with a disease may be important themselves or may be in linkage disequilibrium 
with the important variant or combination of variants. 
5. Defining the phenotype. It is important to define the phenotype based on physiologic and clinical criteria. This enables 
replication of the genetic association study.  
6. Definition of the type of study: case-control, cohort study, family study. 
7. Genotyping error. First and foremost, we need valid genotyping methods like TaqMan, Sequenom (mass spectrometry), 
rapid throughput sequencing. To avoid genotyping error, two independent genotypers should be employed & they 
should be blinded to the case-control status of the subject. Additionally, a repetition of the genotyping in a randomly 
chosen subgroup of subjects using the same or a different technique to ensure genotyping accuracy. 
8. Matching cases & controls. Choosing the cases and the controls according to specific criteria & more details like age, 
gender etc. could provide homogeneity to the groups. In case of known gene-environment interaction the ideal control 
group would be exposed to the relevant environmental influences but free from the case condition. 
Confounders 
9. Population stratification. Cases and controls should be matched for ethnicity because otherwise allele frequencies may 
vary by ethnicity leading to artificial associations. But in diverse areas of the world, like United States, this problem 
could be addressed by:  
 genotyping a large set of unlinked markers in all cases and controls,  
 by using family-based association studies and the transmission disequilibrium test, in which two parents and 
the case patient are genotyped to determine the rate of transmission of the candidate gene polymorphism 
alleles to the affected offspring. In the transmission disequilibrium test a heterozygous parent is expected to 
transmit either allele 50% of the time. In a cohort of affected children, if the transmission of an allele is 
statistically different from the expected 50%, then this polymorphism is significantly associated with disease 
susceptibility.  
 genotyping of ancestry informative markers (AIMs). Also, the large number of SNPs identified in GWAS studies 
provides another mechanism for performing this analysis.   
10. Confounding factors as age, gender and other uncontrolled factors should be analyzed as well by performing 
multivariate analysis for their effect on the results of the study. 
11. Hardy-Weinberg Equilibrium is a formula that describes the genotype frequencies in a population and can be used to 
track their changes from one generation to the next. If the control group is not in Hardy-Weinberg Equilibrium we 
conclude that there has been genotyping errors, inbreeding, genetic drift, new mutations or population substructure.  
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12. Population size determination. The number of cases required to detect positive associations depends on the frequency 
of the less common allele, so a power calculation should be performed. 
13. When  
 genotyping cases and controls studied previously for other polymorphisms,  
 more than one phenotype is analyzed in the study,  
 more than two genes or more than two alleles are under study,  
multiple comparisons are needed.   
14. In the case of multiple comparisons, the potential for type I error increases. Addressing the problem by correction 
(Bonferroni) or via repeating a positive association in a separate set of cases and controls to confirm the finding so that 
the likelihood of a spurious association be reduced. 
15. Replication. Replication of a genetic association is considered when the association is repeated by different 
investigators in different populations, for example the same SNP with the exact same phenotype in two or more 
populations ([23]). Criteria for replication, as stated by NCI-NHGRI Working Group ([24]) on replication in association 
studies, are: 
 sufficient sample size, to convincingly distinguish the proposed effect from no effect 
 independent data sets, to avoid the tendency to split one well-powered study into two less conclusive ones 
 the same or similar phenotype should be analyzed  
 a similar population should be studied and notable differences between the populations studied in the initial 
and attempted replication studies should be described 
 similar magnitude of effect and significance should be demonstrated, in the same direction, with the same 
SNP or a SNP in perfect or very high linkage disequilibrium with the prior SNP (r2 close to 1) 
 statistical significance should be first obtained using the genetic model reported in the initial study 
 when possible, a joint or combined analysis should lead to a smaller P- value than that seen in the initial 
report 
 a strong rationale should be provided for selecting SNPs to be replicated from the initial study, including 
linkage disequilibrium structure, putative functional data or published literature 
 the level of detail for study design and analysis plan should be the same as reported in the initial study  
In this case specifically the phenotype is type 2 diabetes.  
The clinical features of type 2 diabetes – distinguishing it from type 1 diabetes & monogenic diabetes –  are: 1) the age of onset 
is usually >25 (but incidence increasing in adolescents, paralleling increasing rate of obesity in children and adolescents), 2) 
weight, >90% at least overweight (overweight when BMI≥25kg/m2 or BMI≥23kg/m2 for Asians ), 3) islet autoantibodies, absent, 
4) C-peptide, normal/high, 5) insulin production, present, 6) family history of diabetes, frequent (75%-90%), 7) diabetic 
ketoacidosis, rare, 8) first line treatment, noninsulin antihyperglycemic agents (gradual dependence on insulin may occur). 
The diagnostic criteria for type 2 diabetes according to World Health Organization (WHO) are 1) fasting glucose (fasting is 
defined as no caloric intake for at least 8 h) ≥ 7mmol/L (126mg/dL) [normal: ≤ 6mmol/L but truly normal is 
probably<5,6mmol/L], 2) 2hr glucose in OGTT ≥ 11,1mmol/L (200mg/dL) [normal: ≤ 7,7mmol/L], 3) HbA1c ≥ 48mmol/mol (6,5%) 
[normal: < 42mmol/mol], 4) In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis a random plasma 
glucose ≥ 11,1mmol/L (200mg/dL). ([2], [25]) 
STUDY ELIGIBILITY CRITERIA (FOR THE META-ANALYSIS) 
In the meta-analysis were included only: 1) case-control studies, 2) studies with distribution of genotypes, in cases and control 
groups, 2) studies in which the diagnosis of type 2 diabetes was conducted using valid published criteria and the control group is 
consisted of healthy or non-diabetic individuals, 3) studies in which valid genotyping methods were used, 4) studies in which 
controls are in Hardy-Weinberg Equilibrium. 
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STATISTICAL METHODS 
The genetic models we examine in this meta-analysis are: 1) the allele contrast model, where the numbers of the risk allele T is 
compared with that of allele C (T vs C), 2) the recessive model, in which the TT genotype is compared with the combined TC+CC 
genotype (TT vs TC+CC), 3) the dominant model, in which the combined TT+TC genotype is compared with the CC genotype 
(TT+TC vs CC), 4) the additive model, in which TT genotype is compared with CC genotype (TT vs CC), 5) the co-dominant model, 
in which the combined TT+CC is compared with TC (TC vs TT+CC). Over-dominance or Under-dominance was established via the 
h-index (Zintzaras E. et al. 2011 [27]). If h<-1 under-dominance, h>+1 overdominance. 
The existence of heterogeneity (determine whether differences between the studies exist or whether variations are due to 
chance) was tested using 1) the Cochran’s Q test  P value<0,10 indicates the presence of heterogeneity, 2) I2 value, which 
quantifies the effect of heterogeneity without depending on the number of studies 0-25% - low, 26-50% - moderate, 75-100% 
- high. Heterogeneity is present when P value(Q)<0,1 & I2>25%. 
Fixed Effects model assumes that 1) the genetic factors have similar effects on disease susceptibility in all the studies 2) the 
observed variations between studies are caused by chance alone.  
Random Effects model assumes that different studies exhibit substantial diversity and assesses intra-study sample errors and 
inter-study variances.   
When heterogeneity exists (Q test  P value<0,10), Random Effects model is used. When Q test  P value>0,10 Fixed Effects 
model & Random Effects model would offer similar results. 
Publication Bias (the studies that show no significant result remain unpublished) may result in the overestimation of the actual 
effect. The existence of the publication bias was checked with Egger’s linear regression test (P value ≤ 0.05  significant 
publication bias).   
This meta-analysis was conducted with the free software MetaGenyo ([28]). 
RESULTS 
QUALITY ASSESSMENT 
 
Criteria H.K. Bid 
2009 
(India) 
FokI, 
BsmI, 
TaqI [34] 
P.N. Mukhopad-
hyaya 
2010 
(India) 
BsmI [35] 
F. Dilmec 
2010 
(Turks) 
ApaI,TaqI [36] 
N.M. Al-Daghri 
2012 
(Saudi) 
FokI, 
BsmI,TaqI, ApaI 
[37] 
J.R. Xu 2014  
(China) 
BsmI,TaqI [38] 
A.Errouagui 
2014 
(Maroc) 
FokI,BsmI, ApaI 
[39] 
Type of study Case-control Case-control Case-control Case-control Case-control Case-control 
Phenotype 
definition 
+ + + + 
Not analyzed 
+ + 
Matching cases 
& controls 
Age & sex 
matched, 
shared 
geography 
A sub-
popuation, but 
30 out of 40 
patients were 
family material 
(related, they 
sould be 
unrelated)  
Age, sex & body 
mass index 
(BMI) matched 
Matched for 
ethnicity 
Matched for 
ethnicity 
Sex matched, 
similar ethnicity 
Relatedness  Not mentioned  + Not mentioned Not mentioned Not mentioned - 
Population Probably. The Probably. The Probably. The Probably. The Probably. The Probably. The 
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10 
stratification genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
multivariate 
analysis 
- - - - - - 
Frequency of 
variants or 
genotype 
distribution 
+ + + + + + 
Haplotype 
analysis 
- - - + + + 
Valid 
genotyping 
methods 
(PCR & 
restriction 
enzyme, 
TaqMan,  
Sequenom, 
Rapid 
throughput 
Sequencing) 
+ + + + + + 
2 independent 
genotypers  
- 
(Not 
independent 
Members of 
the same lab) 
- - - - - 
Genotypers 
blinded to the 
case-control 
status 
- 
(not stated) 
- - - + - 
Re-sequencing 
in a target sub-
population 
+ - - - - - 
Hardy 
Weinberg 
Equilibrium 
+ + + + + + 
Population size 
determination  
according to 
power 
- - - - - - 
Multiple tests - - - + + + 
Correction 
(Multiple 
- - - + + + 
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tests) 
Replication  - 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
 
 
 
Criteria B. Angel 
2015 
(Chile) 
FokI, [40] 
 
E.A. Rivera-Leon 
2015 
(Mexico) 
ApaI,TaqI [41] 
I.Mahjoubii 
2016 
(Tunisia) 
FokI, [42] 
 
F. YU 
2016 
(China) 
FokI,BsmI [43]    
A.Darraji 
2017 
(Iraq) 
FokI,BsmI,ApaI,TaqI[44] 
Type of study Case-control Case-control Case-control Case-control Case-control 
Phenotype 
definition 
+ + 
Not analyzed 
+ 
 
+ + 
Fasting blood 
sugar>140mg/dl(not 
126mg/dl) 
Matching cases 
& controls 
Gender 
comparable 
- Matched for 
ethnicity 
Age & sex 
matched, HAN 
sub-population 
Age & sex matched  
Relatedness Not mentioned Not mentioned - Not mentioned Not mentioned 
Population 
stratification 
Probably. The 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
Probably. The 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
Probably. The 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
Probably. The 
genotyping of 
ancestry 
informative 
markers (AIMs) 
not done 
Probably. The genotyping 
of ancestry informative 
markers (AIMs) not done 
multivariate 
analysis 
- - - - - 
Frequency of 
variants or 
genotype 
distribution 
+ + + + + 
Haplotype 
analysis 
- + 
Not analyzed 
- + - 
Valid 
genotyping 
methods 
(PCR & 
+ + + + + 
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restriction 
enzyme, 
TaqMan,  
Sequenom, 
Rapid 
throughput 
Sequencing) 
2 independent 
genotypers  
- - + Automatic 
Genotyping 
- 
Genotypers 
blinded to the 
case-control 
status 
- 
(not stated) 
- - Automatic 
Genotyping 
- 
Re-sequencing 
in a target sub-
population 
- - + After quality 
control 1,6% of 
samples excluded 
- 
Hardy Weinberg 
Equilibrium 
+ + + + + 
Population size 
determination  
according to 
power 
- - - - - 
Multiple tests - - - - - 
Correction 
(Multiple tests) 
- - - - - 
Replication  - 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination 
according to 
power 
 
- 
No sample size 
determination according 
to power 
 
 
 
Criteria Z. Xia 
2017 
(China) 
ApaI,TaqI, FokI, 
BsmI [45] 
D. Sarma 
2018 
(India) 
FokI, 
BsmI TaqI [46]  
B. Angel 2018 
(Chille) 
FokI, 
BsmI [47] 
Type of study Case-control Case-control Case-control 
Phenotype definition + + + 
Matching cases & 
controls 
Age & sex matched, HAN 
nationality 
Age & sex matched, HAN 
nationality 
- 
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Population 
stratification 
Probably. The genotyping of 
ancestry informative markers 
(AIMs) not done 
Probably. The genotyping of 
ancestry informative markers 
(AIMs) not done 
Probably. The genotyping of 
ancestry informative markers 
(AIMs) not done 
multivariate analysis - - - 
Frequency of variants 
or genotype 
distribution 
+ + + 
Haplotype analysis - - - 
Valid genotyping 
methods 
(PCR & restriction 
enzyme, TaqMan,  
Sequenom, Rapid 
throughput 
Sequencing) 
+ + + 
2 independent 
genotypers  
- - - 
Genotypers blinded to 
the case-control status 
- - - 
Re-sequencing in a 
target sub-population 
- - - 
Hardy Weinberg 
Equilibrium 
+ - + 
Population size 
determination  
according to power 
- - - 
Multiple tests - - - 
Correction (Multiple 
tests) 
- - - 
Replication  - 
No sample size determination 
according to power 
 
- 
No sample size determination 
according to power 
 
- 
No sample size determination 
according to power 
 
 
 
 
META-ANALYSIS  
To overcome the problem of small sample sizes and the inadequate statistical strength and precision, for each polymorphism a 
meta-analysis was performed to identify a genuine association. In this meta-analysis, only good quality studies (in HWE) were 
included. 
Meta-analysis for TaqI polymorphism  
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Studies Distribution of TaqI (rs 731236) VDR genotype 
First author, ethnicity, year Cases Controls HWE 
P-
value 
HWE 
adjusted 
P-value 
TT 
(TT) 
TC 
(Tt)  
CC 
(tt) 
TT 
(TT) 
TC 
(Tt) 
CC 
(tt) 
H. K. Bid, India (Caucasians), 2009 36 49 15 67 65 28 0.085 0.2493 
F. Dilmec, Turkey (Caucasians), 2010 33 25 14 69 81 19 0.5112 0.5842 
R. J. Xu, China – Hui (descendants of Arabic & Persian 
merchants, over 12 million people in China), 2014 
3 17 134 0 16 99 0.4227 0.5842 
R. J. Xu, China – Han (East Asians), 2014 0 19 182 1 25 188 0.8638 0.8638 
Al-Darraji SZ, Iraq (Caucasians), 2017 78 95 27 15 44 16 0.1329 0.2658 
E.-A. Rivera-Leon, Mexico (Mix), 2015  38 62 25 34 72 19 0.0591 0.2493 
D. Sarma, India (Caucasians), 2018 22 10 8 14 4 2 0.0935 0.2493 
Z. Xia, China – Han (East Asians), 2017 224 18 0 86 14 0 0.4516 0.5842 
Total  434 295 405 286 321 371   
Total number of cases & controls 1134 978   
Table 1. Genotype distribution and Hardy-Weinberg Equilibrium for TaqI polymorphism 
All the studies are in HWE (p≥0.05) as seen above (table 1). The results of the meta-analysis under each genetic model, are: 1) 
allele contrast (T vs C) RE OR=1.0550 / 95% CI = (0.8233, 1.3520) / P value(Q) = 0.0497 / I2 = 50.29%, 2) recessive model (TT vs 
TC+CC) RE OR=1.2667 / 95% CI = (0.8555, 1.8755) / P value(Q) = 0.0598 / I2 = 48.34%, 3) dominant model (TT+TC vs CC) FE 
OR=0.8923 / 95% CI = (0.6781, 1.1742) / P value(Q) = 0.2641 / I2 = 21.67%, 4) additive model (TT vs CC) RE OR=1.0478 / 95% CI 
= (0.5935, 1.8500) / P value(Q) = 0.0875 / I2 = 45.6%.  
Under the co-dominant model (TC vs TT+CC), there is no heterogeneity (variations are due to chance) since P value(Q) = 0.25 / 
I2 =22.55 % and FE OR=0.776/ 95% CI = (0.625, 0.964) is significant, RE OR=0.771 / 95% CI = (0.600, 0.991) is also significant (fig. 
1 Forest Plot). Under-dominance, which means that there is smaller chance for the heterozygotes to be affected by diabetes 
type 2, is established via h-index, h= ln (OR co-dominant)/|ln (OR additive)|=-5.43<-1.  
We conduct a Sensitivity analysis, in which the effect size is assessed by leaving out the study/ies with the biggest weight – w. 
After leaving out the heaviest study – (Mexico w = 15.44), P value(Q) = 0.177 (no heterogeneity, variations are due to chance), 
FE OR=0.788/ 95% CI = (0.620, 1.003) marginally not significant, RE OR=0.788/ 95% CI = (0.576, 1.053)  not significant. After 
leaving out the 2 heaviest studies – (Mexico w = 15.44, India w = 15.17), P value(Q) = 0.792 (no heterogeneity, variations are 
due to chance), FE OR=0.664/ 95% CI = (0.505, 0.874)  significant, RE OR=0.644/ 95% CI = (0.558, 0.744)  significant. After 
leaving out the 3 heaviest studies – (Mexico w = 15.44, India w = 15.17, Iraq w = 13.33), P value(Q) = 0.669 (no heterogeneity, 
variations are due to chance), FE OR=0.674/ 95% CI = (0.490, 0.927)  significant, RE OR=0.654/ 95% CI = (0.528, 0.813)  
significant. After leaving out the 4 heaviest studies – (Mexico w = 15.44, India w = 15.17, Iraq w = 13.33, Turkey w = 11.77), P 
value(Q) = 0.581 (no heterogeneity, variations are due to chance), FE OR=0.723/ 95% CI = (0.492, 1.060)  not significant, RE 
OR=0.719/ 95% CI = (0.541, 0.956)  significant. Additionally, sensitivity analysis by MetaGenyo software showed that: a) Fixed 
Effect model OR = 0.78 / 95% CI = (0.62, 0,96) significant, b) Random Effect model OR = 0.77 / 95% CI = (0.60, 0,99)  
significant, as seen in fig.2 and fig. 3.  
The possibility of Publication bias was checked by Funnel Plot (fig. 4) and Egger’s test, where the P value = 0.9578 > 0.05 which 
means that there is no significant publication bias.  
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Fig. 1  Forest plot, Fixed Effect model and Random Effects model for TaqI polymorphism under the co-dominant model (TC vs 
TT+CC) 
 
Fig. 2 Leave -1- out forest plot, Fixed Effect model under the co-dominant model 
 
 
 
 
 
 
 
 
Fig. 3 Leave -1- out forest plot, Random Effect model under the co-dominant model 
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Fig. 4 Funnel Plot under the co-dominant model 
 
Meta-analysis for BsmI polymorphism  
Studies Distribution of BsmI (rs 1544410) VDR genotype 
First author, ethnicity, year Cases Controls HWE 
P-
value 
HWE 
adjusted 
P-value 
GG 
(BB) 
GA 
(Bb)  
AA 
(bb) 
GG 
(BB) 
GA 
(Bb) 
AA 
(bb) 
H. K. Bid, India (Caucasians), 2009 30 52 18 60 77 23 0.8309 0.8309 
P. N. Mukhopadhyaya, India (Caucasians), 2010 17 9 14 26 10 4 0.0733 0.2401 
R. J. Xu, China – Hui (descendants of Arabic & Persian 
merchants, over 12 million people in China), 2014 
122 30 2 87 28 0 0.1372 0.2401 
R. J. Xu, China – Han (East Asians), 2014 176 24 1 172 47 0 0.0753 0.2401 
Errouagui, Maroc (Caucasians), 2014 18 57 60 18 57 61 0.4233 0.5926 
F. Yu, China – Han (East Asians), 2016  354 43 0 698 75 3 0.5201 0.6068 
D. Sarma, India (Caucasians), 2018 12 23 5 10 6 4 0.1276 0.2401 
Total  729 238 100 1071 300 95   
Total number of cases & controls 1067 1466   
Table 2. Genotype distribution and Hardy-Weinberg Equilibrium for BsmI polymorphism 
All the studies are in HWE (p≥0.05) as seen above (table 2). If we consider Chinese Hui population as Caucasians – with dark 
skin [including Indians and Moroccans], since they are descendants of Arabic & Persian merchants, the results of the meta-
analysis under each genetic model show no significant association.  
In detail: 1) allele contrast (A vs G), a] overall RE OR=1.0936 / 95% CI = (0.8137, 1.4697) / P value(Q) = 0.0132 / I2 = 62.75%, b] 
Caucasians  RE OR=1.2595 / 95% CI = (0.8973, 1.7679) / P value(Q) = 0.0583 / I2 = 56.13%, c] East Asians (Han Chinese)  RE 
OR=0.7915 / 95% CI = (0.4439, 1.4113) / P value(Q) = 0.0645 / I2 = 70.73%, 2) recessive model (AA vs AG+GG), a] overall  RE 
OR= 1.1937 / 95% CI = (0.8387, 1.6990) / P value(Q) = 1.1957 / I2 = 30.45%, b] Caucasians  FE OR=1.204 / 95% CI = (0.8419, 
1.7218) / P value(Q) = 0.1202 / I2 = 45.31%, c] East Asians (Han Chinese)  RE OR=0.8679 / 95% CI = (0.0984, 7.6560) / P 
value(Q) = 0.2678 / I2 = 18.56%, 3) Dominant model (AA + AG vs GG), a] overall  RE OR=1.089 / 95% CI = (0.7590, 1.5629) / P 
value(Q) = 0.0269 / I2 = 57.9%, b] Caucasians  FE OR=1.2509 / 95% CI = (0.9198, 1.7010) / P value(Q) = 0.1832 / I2 = 35.7 %, c] 
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East Asians  RE OR=0.7684 / 95% CI = (0.3734, 1.5812) / P value(Q) = 0.0283 / I2 =79.21 %, 4) Co-dominant (AG vs AA+GG), a] 
overall  RE OR=0.9597 / 95% CI = (0.7002, 1.3153) / P value(Q) = 0.0609 / I2 = 50.2%, b] Caucasians  RE OR=1.0463 / 95% CI = 
(0.7924, 1.3816) / P value(Q) = 0.2732 / I2 = 22.19 %, c] East Asians  RE OR=0.766 / 95% CI = (0.3407, 1.7220) / P value(Q) = 
0.0148 / I2 =83.18 %, 5) additive (AA vs GG), a] overall  FE OR=1.4762 / 95% CI = (0.9398, 2.3189) / P value(Q) = 0.3191 / I2 = 
14.52%, b] Caucasians  FE OR=1.515 / 95% CI = (0.9549, 2.4038) / P value(Q) = 0.2284 / I2 = 28.97 %, c] East Asians  FE 
OR=0.829 / 95% CI = (0.0939, 7.3162) / P value(Q) = 0.2931 / I2 = 9.53 %. 
If we consider Hui population as a genetically different ethnic group that is distinct from Caucasians (their marriage practices 
tend towards endogamy leading to a distinct genetic pool), the results of the meta-analysis show that under the dominant 
genetic model there is a statistically significant association in the subgroup of Caucasians [FE OR=1.4824 / 95% CI = (1.0309, 
2.1317) / P value(Q) = 0.3528 / I2 = 8.07 % (no heterogeneity].  
The results in detail are: 1) allele contrast (A vs G), a] overall RE OR=1.0936 / 95% CI = (0.8137, 1.4697) / P value(Q) = 0.0132 / 
I2 = 62.75%, b] Caucasians  RE OR=1.3803 / 95% CI = (0.9225, 2.0653) / P value(Q) = 0.0503 / I2 = 61.54%, c] East Asians (Han 
Chinese)  RE OR=0.7915 / 95% CI = (0.4439, 1.4113) / P value(Q) = 0.0645 / I2 = 70.73%, 2) recessive model (AA vs AG+GG), a] 
overall  RE OR= 1.1937 / 95% CI = (0.8387, 1.6990) / P value(Q) = 1.1957 / I2 = 30.45%, b] Caucasians  RE OR=1.3137 / 95% CI 
= (0.6975, 2.4741) / P value(Q) = 0.0799 / I2 = 55.64%, c] East Asians (Han Chinese)  FE OR=0.8679 / 95% CI = (0.0984, 7.6560) / 
P value(Q) = 0.2678 / I2 = 18.56%, 3) Dominant model (AA + AG vs GG), a] overall  RE OR=1.089 / 95% CI = (0.7590, 1.5629) / P 
value(Q) = 0.0269 / I2 = 57.9%, b] Caucasians  FE OR=1.4824 / 95% CI = (1.0309, 2.1317)  significant / P value(Q) = 0.3528 / 
I2 = 8.07 % (no heterogeneity, variations are due to chance), Egger’s test (Caucasians) - P value = 0.3587 > 0.05  not significant 
publication bias, c] East Asians  RE OR=0.7684 / 95% CI = (0.3734, 1.5812) / P value(Q) = 0.0283 / I2 =79.21 % (fig. 5 Forest 
Plot), 4) Co-dominant (AG vs AA+GG), a] overall  RE OR=0.9597 / 95% CI = (0.7002, 1.3153) / P value(Q) = 0.0609 / I2 = 50.2%, 
b] Caucasians  FE OR=1.153 / 95% CI = (0.8404, 1.5818) / P value(Q) = 0.315 / I2 = 15.36 %, c] East Asians  RE OR=0.766 / 
95% CI = (0.3407, 1.7220) / P value(Q) = 0.0148 / I2 =83.18 %, 5) additive (AA vs GG), a] overall  FE OR=1.4762 / 95% CI = 
(0.9398, 2.3189) / P value(Q) = 0.3191 / I2 = 14.52%, b] Caucasians  FE OR=1.4848 / 95% CI = (0.9308, 2.3686) / P value(Q) = 
0.1498 / I2 = 43.62 %, c] East Asians  FE OR=0.829 / 95% CI = (0.0939, 7.3162) / P value(Q) = 0.2931 / I2 = 9.53 %. 
 
Fig. 5  Forest plot, Fixed Effect model and Random Effects model for BsmI polymorphism under the dominant model (ΑΑ+ ΑG vs 
GG) 
If we exclude the study (India 2010) – because it included 30 (out of 40) patients that are related – in the subgroup analysis: in 
the subgroup of Caucasians (Morocco, India, Hui Chinese)  FE OR=1.142 / 95% CI = (0.823, 1.583) / RE OR=1.149 / 95% CI = 
(0.796, 1.659)  not significant, P value(Q) = 0.305 (no heterogeneity) and if Hui Chinese are not included in the subgroup of 
Caucasians (Morocco, India)  FE OR=1.339 / 95% CI = (0.900, 1.991) / RE OR=1.334 / 95% CI = (0.942, 1.891)  not significant, 
P value(Q) = 0.428 (no heterogeneity).  
The Sensitivity analysis, in which the effect size is assessed by leaving out the study/ies with the biggest weight – w. After leaving 
out the heaviest study – (China-Han 2016 w = 24.79), P value(Q) = 0.015 (heterogeneity), RE OR=1.116/ 95% CI = (0.700, 1.781) 
 not significant. After leaving out the 2 heaviest studies – (China-Han 2016 w = 24.79, China-Han 2014 w = 13.74), P value(Q) = 
0.183 (no heterogeneity, variations are due to chance), FE OR=1.251/ 95% CI = (0.920, 1.701)  not significant, RE OR=1.302/ 
95% CI = (0.873, 1.940) not significant. After leaving out the 3 heaviest studies – (China-Han 2016 w = 24.79, China-Han 2014 
w = 13.74, India 2009 w = 13.46), P value(Q) = 0.113 (no heterogeneity, variations are due to chance), FE OR=1.183/ 95% CI = 
(0.812, 1.723)  not significant, RE OR=1.316/ 95% CI = (0.754, 2.294)  not significant. After leaving out the 4 heaviest studies 
– (China-Han 2016 w = 24.79, China-Han 2014 w = 13.74, India 2009 w = 13.46, China-Hui 2014 w = 11.54), P value(Q) = 0.204 
(no heterogeneity, variations are due to chance), FE OR=1.557/ 95% CI = (0.949, 2.556)  not significant, RE OR=1.651/ 95% CI 
= (0.867, 3.144)  not significant. Additionally, the Sensitivity Analysis by MetaGenyo software result can be seen in fig. 6 and 
fig. 7. 
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The possibility of Publication bias was checked by Funnel Plot (fig. 8) and Egger’s test  P value = 0.2884 > 0.05  not 
significant publication bias. 
 
Fig. 6 Leave -1- out forest plot, Fixed Effect model under the dominant model 
 
Fig. 7 Leave -1- out forest plot, Random Effect model under the dominant model 
 
Fig. 8 Funnel Plot under the dominant model 
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Meta-analysis for FokI polymorphism  
Studies Distribution of FokI (rs 2228570) VDR genotype 
First author, ethnicity, year Cases Controls HWE 
P-value 
HWE 
adjusted 
P-value 
CC (FF) CT (Ff)  TT (ff) CC (FF) CT (Ff)  TT (ff) 
N.M. Al-Daghri, (Caucasians), 2012 22 133 213 19 111 129 0.4613 0.565 
Errouagui, Maroc (Caucasians), 2014 87 80 9 82 74 21 0.4962 0.565 
F. Yu, China – Han (East Asians), 2016 112 205 80 223 405 147 0.1236 0.3708 
I.Mahjoubi, Tunisia (Caucasians), 2016 231 180 28 168 117 17 0.565 0.565 
B.Angel, Chile(Mix), 2015 24 96 40 53 75 32 0.5601 0.565 
B.Angel, Chile(Mix), 2018 24 86 28 38 81 53 0.5042 0.565 
Z. Xia, China – Han (East Asians), 2017 129 94 19 38 50 12 0.4684 0.565 
Total  637 874 449 623 916 426   
Total number of cases & controls 1960 
 
1965   
Table 3. Genotype distribution and Hardy-Weinberg Equilibrium for FokI polymorphism 
All the studies are in HWE (p≥0.05) as seen above (table 3). The results of the meta-analysis show that under the co-dominant 
genetic model (CT vs CC+TT) [FE OR=1.775/ 95% CI = (1.2916, 2.4393) / P value(Q) = 0.7842 / I2 = 0%] and under the model (CC 
vs CT) [FE OR=0.4536/ 95% CI = (0.3007, 0.6845)/ P value(Q) = 0.2158 / I2 = 34.74%] there is a statistically significant association 
in the subgroup of Mixed population.  
The results of the meta-analysis under each genetic model in detail are: 1) allele contrast (C vs T), a] overall RE OR=0.9805 / 
95% CI = (0.8105, 1.1862) / P value(Q) = 0.0018 / I2 = 71.43%, b] Caucasians  RE OR=0.9480 / 95% CI = (0.7373, 1.2190) / P 
value(Q) = 0.0726 / I2 = 61.88%, c] East Asians (Han Chinese)  RE OR=1.1993 / 95% CI = (0.7483, 1.9219) / P value(Q) = 0.015 / 
I2 = 83.11%, d] Mix RE OR=0.8397/ 95% CI = (0.4749, 1.4848) / P value(Q) = 0.0104 / I2 = 84.75%, 2) recessive model (CC vs 
CT+TT), a] overall  RE OR= 0.8948 / 95% CI = (0.6586, 1.2157) / P value(Q) = 0.0012 / I2 = 72.68%, b] Caucasians  FE 
OR=0.9396 / 95% CI = (0.7503, 1.768) / P value(Q) = 0.5612 / I2 = 0%, c] East Asians (Han Chinese)  RE OR=1.3049 / 95% CI = 
(0.6924, 2.4592) / P value(Q) = 0.0198 / I2 = 81.57%, d] Mix RE OR=0.5118/ 95% CI = (0.2493, 1.0509) / P value(Q) = 0.0677 / I2 
= 70.05%, 3) Dominant model (CC + CT vs TT), a] overall  RE OR=1.0772 / 95% CI = (0.7906, 1.4675) / P value(Q) = 0.0133 / I2 = 
62.69%, b] Caucasians  RE OR=0.0690 / 95% CI = (0.5602, 2.0400) / P value(Q) = 0.0203 / I2 = 74.34 %, c] East Asians  FE 
OR=0.9994 / 95% CI = (0.7535, 1.3255) / P value(Q) = 0.1933 / I2 =40.91 %, d] Mix RE OR=1.1458 / 95% CI = (0.4995,2.6280) / P 
value(Q) = 0.0258 / I2 = 79.87%, 4) Co-dominant (CT vs CC+TT), a] overall  RE OR=1.0787 / 95% CI = (0.8420, 1.3819) / P 
value(Q) = 0.0033 / I2 = 69.33%, b]Caucasians  FE OR=0.9709 / 95% CI = (0.7987, 1.1803) / P value(Q) = 0.1614 / I2 = 45.18 %, c] 
East Asians  FE OR=0.8914 / 95% CI = (0.7188, 1.1054) / P value(Q) = 0.1114 / I2 =60.53 %, d] Mix FE OR=1.775/ 95% CI = 
(1.2916, 2.4393) / P value(Q) = 0.7842 / I2 = 0%  significant, 4) additive (CC vs TT), a] overall  RE OR=0.9872 / 95% CI = 
(0.6504, 1.4985) / P value(Q) = 0.0055 / I2 = 67.24%, b] Caucasians  RE OR=1.0797 / 95% CI = (0.5363, 2.1737) / P value(Q) = 
0.0509 / I2 = 66.41 %, c] East Asians  RE OR=1.2966 / 95% CI = (0.5765, 2.9162) / P value(Q) = 0.0612 / I2 = 71.47 %, d] Mix 
RE OR=0.6565/ 95% CI = (0.2038, 2.1153) / P value(Q) = 0.0147 / I2 = 83.21%, 5) (CC vs CT), a] overall  RE OR=0.8713 / 95% CI = 
(0.6399, 1.1864) / P value(Q) = 0.0024 / I2 = 70.49%, b] Caucasians  FE OR= 0.9272 / 95% CI = (0.7334, 1.1722) / P value(Q) = 
0.9346 / I2 = 0 %, c] East Asians  RE OR=1.2903 / 95% CI = (0.7208, 2.3099) / P value(Q) = 0.0406 / I2 = 76.16 %, d] Mix FE 
OR=0.4536/ 95% CI = (0.3007, 0.6845) / P value(Q) = 0.2158 / I2 = 34.74%  significant.  
Over-dominance (bigger chance for the heterozygotes to be affected by diabetes type 2) in the mixed population (cases-298, 
controls-332) is established via h-index, h= ln (OR co-dominant)/|ln (OR additive)|=+1.3675>+1. 
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We conduct a Sensitivity analysis (the effect size is assessed by leaving out the study/ies with the biggest weight – w). After 
leaving out the heaviest study – (China-Han 2016 w = 65.54), P value(Q) = 0.002 (heterogeneity), RE OR=1.106/ 95% CI = (0.808, 
1.514)  not significant. After leaving out the 2 heaviest studies – (China-Han 2016 w = 65.54, Τunisia 2016 w = 42.79), P 
value(Q) = 0.001 (heterogeneity), RE OR=1.111/ 95% CI = (0.738, 1.672)  not significant. After leaving out the 3 heaviest 
studies – (China-Han 2016 w = 65.54, Τunisia 2016 w = 42.79, Saudi 2012 w = 36.31), P value(Q) = 0.005 (heterogeneity, 
variations are due to chance), RE OR=1.239/ 95% CI = (0.780, 1.967)  not significant. The Sensitivity Analysis by MetaGenyo 
software is shown in fig.9 and fig.10. 
The possibility of Publication bias was checked by Funnel Plot (fig. 11) and Egger’s test P value = 0.6933  not significant 
publication bias. 
 
Fig. 9 Leave -1- out forest plot, Fixed Effect model under the overdominant model 
 
Fig. 10 Leave -1- out forest plot, Fixed Effect model under the overdominant model 
 
 
 
 
Fig. 11 Funnel Plot under the overdominant model 
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Meta-analysis for ApaI polymorphism  
Studies Distribution of ApaI (rs 7975232) VDR genotype 
First author, ethnicity, year Cases Controls HWE 
P-value 
HWE 
adjusted 
P-value 
TT (AA) TG (Aa)  GG (aa) TT (AA) TG (Aa)  GG (aa) 
F. Dilmec, Turkey (Caucasians), 2010 27 38 7 61 82 26 0.8566 0.8566 
Errouagui, Maroc (Caucasians), 2014 36 89 34 36 90 34 0.1133 0.307 
Z. Xia, China – Han (East Asians), 2017 19 92 131 13 38 49 0.2047 0.307 
Total  82 219 172 110 210 109   
Total number of cases & controls 473 429   
Table 4. Genotype distribution and Hardy-Weinberg Equilibrium for ApaI polymorphism 
 
All the studies are in HWE (p≥0.05) as seen above (table 4). No significant association was detected.  
The results of the meta-analysis under each genetic model, are: 1) allele contrast (G vs T) FE OR=1.0422 / 95% CI = (0.8508, 
1.2767) / P value(Q) = 0.3315 / I2 = 9.43% and in Caucasians  FE OR=0.9456 / 95% CI = (0.7393, 1.2095) / P value(Q) = 0.5636 / 
I2 = 0%, 2) recessive model (GG vs GT+TT) FE OR=1.0330 / 95% CI = (0.7449, 1.4325) / P value(Q) = 0.3577 / I2 = 2.73% and in 
Caucasians  FE OR=0.8739 / 95% CI = (0.5526, 1.3820) / P value(Q) = 0.3136 / I2 = 1.5%, 3) dominant model (GG+GT vs TT) FE 
OR=1.0976 / 95% CI = (0.7787, 1.5473) / P value(Q) = 0.3811 / I2 = 0% and in Caucasians  FE OR=0.9684 / 95% CI = (0.6580, 
1.4254) / P value(Q) = 0.8948 / I2 = 0%, 4) additive model (GG vs TT) RE OR=1.0926 / 95% CI = (0.6998, 1.7060) / P value(Q) = 
0.2004 / I2 = 37.79% and in Caucasians  FE OR=0.8497 / 95% CI = (0.4934, 1.4633) / P value(Q) = 0.4001 / I2 = 0%, 5) co-
dominant (GT vs TT+GG)  FE OR=1.0404/ 95% CI = (0.7861, 1.3770) /P value(Q) = 0.8644 / I2 =0 % and in Caucasians  FE 
OR=1.0616 / 95% CI = (0.7517, 1.4993) / P value(Q) = 0.615 / I2 = 0%. 
 
Fig. 12  Forest plot, Fixed Effect model and Random Effects model for BsmI polymorphism under allele contrast (G vs T) 
Sensitivity Analysis by MetaGenyo software in fig. 13 and fig.14. The possibility of Publication bias was checked by Funnel Plot 
(fig. 11) and Egger’s test  P value = 0.8532  not significant publication bias. 
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Fig. 13 Leave -1- out forest plot, Fixed Effect model under the allele contrast 
 
Fig. 14 Leave -1- out forest plot, Random Effect model under the allele contrast 
 
 
Fig. 15 Funnel Plot under allele contrast (G vs T) 
 
CONCLUSIONS 
According to Zintzaras E. et al. in 2008 ([26]), meta-analysis provides a robust tool to investigate contradictory results in genetic 
association studies by estimating population-wide effects of genetic risk factors in diseases and explaining sources of bias and 
heterogeneity. 
For TaqI polymorphism, overall (Caucasians – with dark skin & East Asians) the results indicate that heterozygotes (TC) are 
protected of type 2 diabetes, since there is 22,4% smaller chance for the heterozygote to be affected by the disease than for the 
homozygotes (TT+CC) [FE OR=0.776/ 95% CI = (0.625, 0.964) is significant, RE OR=0.771 / 95% CI = (0.600, 0.991) is also 
significant]. In favor of these results is the fact that 1134 cases & 978 controls were included, there was no heterogeneity (P 
value(Q) = 0.25 / I2 =22.55 %) and no significant publication bias was detected (as indicated by Egger’s test: P value = 0.9578 > 
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0.05 and a funnel plot). On the other hand, the sensitivity analysis shows contradicting results, although Fixed Effect model OR = 
0.78 / 95% CI = (0.62, 0,96) significant and Random Effect model OR = 0.77 / 95% CI = (0.60, 0,99)  significant. 
TaqI polymorphism is located inside exon 9 and the protein coded remains the same.  It has been shown by C. Andraos et al. in 
2011 [29] that the variant is inside CpG5 of CGI1060 and the C allele is always methylated gradually reducing vdr protein levels 
and additionally it has been stated by D. Saccone et al. in 2015 [30] that C allele(t) is associated with lower levels of vdr protein 
and TT genotype is associated with higher levels of vdr protein ([31]). However, it is known ([20]) that low levels of vdr protein is 
associated with dysfunction of β cells and type 2 diabetes. The above can explain why CC genotype has higher risk of type 2 
diabetes than TC. On the other hand, there has been an indication that T allele is associated with obesity in Greek population 
([32]) so it is possible that TT genotype is increasing the risk of diabetes via obesity, since vdr protein is an important 
transcription factor and obesity-induced β cell dysfunction is poorly understood. 
For BsmI polymorphism, in Caucasians – with dark skin [Hui not included] (subgroup analysis) the results indicate that carriers of 
the A allele (AA+AG) have 48,2% higher risk of acquiring type 2 diabetes [FE OR=1.4824 / 95% CI = (1.0309, 2.1317)] which is 
significant. In favor of these results is the fact that there was no heterogeneity, which means that variations are due to chance 
(because P value(Q) = 0.3528 / I2 = 8.07 %) and no significant publication bias was detected (as indicated by Egger’s test: P value 
= 0.3587 > 0.05 and a funnel plot). The results should be viewed with caution mainly because no significant association has been 
shown after the exclusion of the study that included relatives and additionally because of the small number of participants (315 
cases & 356 controls).  
For FokI polymorphism, in Mixed population – (subgroup analysis) the results indicate that heterozygotes CT have 77,5% higher 
risk of acquiring type 2 diabetes compared to the homozygotes (CC+TT) [FE OR=1.775/ 95% CI = (1.2916, 2.4393)] which is 
significant. In favor of these results is the fact that there was no heterogeneity, which means that variations are due to chance 
in CT vs CC+TT model (P value(Q) = 0.7842 / I2 = 0%). Additionally, heterozygotes CT have 102,5% higher risk of acquiring type 2 
diabetes compared to the homozygotes CC [ CC vs CT, FE OR=0.4536/ 95% CI = (0.3007, 0.6845)] which is significant but there 
was medium heterogeneity (P value(Q) = 0.2158 / I2 = 34.74%). On the other hand, the number of participants (298 cases & 332 
controls) is small. 
FokI polymorphism is located inside the exon 2 and the C allele codes a shorter protein that has a higher trans-activational 
capacity – as shown be Arai et al. in 1997 [33] – and therefor FokI may indirectly affect VDR regulation through autoregulation. 
As stated by D. Saccone et al. in 2015 [30], the risk presumably is modified by influencing VDR protein levels and VDR trans-
activation capacity. 
For ApaI polymorphism no significant associations were found. There was no heterogeneity under each genetic model [except 
for the additive model (GG vs TT) where medium heterogeneity was found (I2 = 37.79%)]. No significant publication bias was 
detected (as indicated by Egger’s test: P value = 0.9578 > 0.05 and a funnel plot). On the other hand, since only 3 studies were 
included, the number of participants (473 cases & 429 controls) is small and ApaI polymorphism is located inside intron 8 
(between exon 8 & 9) and no known functional consequence has been described.  
Consequently, further analysis should be conducted to shed light on the exact association of VDR with type 2 diabetes. This 
meta-analysis though, does indicate a possible association. 
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